Karl Fabian Uy to Neoplasm Staging
This is a "connection" page, showing publications Karl Fabian Uy has written about Neoplasm Staging.
Connection Strength
0.320
-
Emmerick ICM, Singh A, Powers M, Lou F, Lin P, Maxfield M, Uy K. Factors associated with diagnosis of stages I and II lung cancer: a multivariate analysis. Rev Saude Publica. 2021; 55:112.
Score: 0.156
-
Uy KL, Darling G, Xu W, Yi QL, De Perrot M, Pierre AF, Waddell TK, Johnston MR, Bezjak A, Shepherd FA, Keshavjee S. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007 Jul; 134(1):188-93.
Score: 0.057
-
Reddington H, Emmerick I, Diaz Collante J, Maini A, Kanzaria R, Crawford A, Phillips W, Maxfield M, Uy K, Lou F. Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer. PLoS One. 2026; 21(6):e0349231.
Score: 0.053
-
Diaz Collante J, Crawford A, Reddington H, Markel A, Epstein M, Gray C, Lou F, Phillips W, Maxfield M, Uy K, Emmerick I. National trends in lung cancer stage, treatment, and time to treatment initiation after a major healthcare disruption (NCDB 2014-2022). J Cancer Policy. 2026 06; 48:100724.
Score: 0.052